Clinical Trials Directory

Trials / Completed

CompletedNCT01752114

Early Diagnosis of Pulmonary Nodules

Early Diagnosis of Pulmonary Nodules Using A Plasma Proteomic Classifier, Protocol Number 1001-12

Status
Completed
Phase
Study type
Observational
Enrollment
684 (actual)
Sponsor
Integrated Diagnostics · Industry
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

This study is intended to determine the positive predictive value (PPV) and negative predictive value (NPV) of the multiprotein classifier based on the observed study prevalence of Non-Small Cell Lung Cancer (NSCLC) in the study participants.

Detailed description

Patients must present with previously non-diagnosed lung nodules as found on CT. There is no change to the typical standard of care that any of the investigating physicians and/or centers provide the patients enrolled in this study. The data from this study will not be used to diagnose cancer nor be used to influence treatment decisions for the study participants.

Conditions

Timeline

Start date
2012-10-01
Primary completion
2016-12-31
Completion
2016-12-31
First posted
2012-12-19
Last updated
2018-03-01

Locations

33 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT01752114. Inclusion in this directory is not an endorsement.